Dashboard
Manage Tickers

CYTH


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

cyclo-therapeutics-shares-are-trading-higher-after-the-company-announced-the-presentation-of-preliminary-data-from-its-ongoing-pivotal-phase-3-study-and-substudy-evaluating-trappsol-cyclo-for-the-treatment-of-niemann-pick-disease-type-c1
Cyclo Therapeutics shares are trading high...
09/05/2024 13:09:01

cyclo-therapeutics-presents-preliminary-data-from-phase-3-study-of-trappsol-cyclo-for-niemann-pick-disease-type-c1-at-ssiem-symposium-topline-data-expected-h1-2025
Cyclo Therapeutics Presents Preliminary Da...
09/05/2024 13:06:33

this-hershey-analyst-turns-bearish-here-are-top-5-downgrades-for-tuesday
This Hershey Analyst Turns Bearish; Here A...
08/27/2024 13:00:52

maxim-group-downgrades-cyclo-therapeutics-to-hold
Maxim Group Downgrades Cyclo Therapeutics ...
08/27/2024 12:32:28

Maxim Group analyst Jason McCarthy downgrades Cyclo Therapeutics (NASDAQ:CYTH) from Buy to Hold.

ascendiant-capital-maintains-buy-on-cyclo-therapeutics-lowers-price-target-to-095
Ascendiant Capital Maintains Buy on Cyclo ...
08/26/2024 10:10:17

Ascendiant Capital analyst Lucas Ward maintains Cyclo Therapeutics (NASDAQ:CYTH) with a Buy and lowers the price target from...

hc-wainwright--co-downgrades-cyclo-therapeutics-to-neutral-lowers-price-target-to-095
HC Wainwright & Co. Downgrades Cyclo Thera...
08/23/2024 11:23:33

HC Wainwright & Co. analyst Swayampakula Ramakanth downgrades Cyclo Therapeutics (NASDAQ:CYTH) from Buy to Neutral and l...

nasdaq-down-over-200-points-williams-sonoma-shares-tumble-after-q2-results
Nasdaq Down Over 200 Points; Williams-Sono...
08/22/2024 18:47:30

gold-down-over-1-us-initial-jobless-claims-increase
Gold Down Over 1%; US Initial Jobless Clai...
08/22/2024 16:16:23

dow-jumps-100-points-bjs-wholesale-earnings-top-estimates
Dow Jumps 100 Points; BJ's Wholesale Earni...
08/22/2024 13:54:09

Core News & Articles
Rafael And Cyclo Therapeutics Have Agreed ...
08/22/2024 10:52:33

On consummation of the merger, Rafael will issue Class B shares to Cyclo Therapeutics' shareholders, based on an exchange r...

hc-wainwright--co-reiterates-buy-on-cyclo-therapeutics-maintains-3-price-target
HC Wainwright & Co. Reiterates Buy on Cycl...
08/16/2024 16:12:53

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Cyclo Therapeutics (NASDAQ:CYTH) with a Buy and maintains ...

cyclo-therapeutics-q2-eps-021-misses-016-estimate-sales-12310k-miss-26750k-estimate
Cyclo Therapeutics Q2 EPS $(0.21) Misses $...
08/15/2024 13:03:11

Cyclo Therapeutics (NASDAQ:CYTH) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of ...

cyclo-therapeutics-receives-grant-notice-from-european-patent-office-for-patent-on-methods-for-treating-alzheimers-disease-european-patent-number-3873604b-to-be-published-on-august-21-2024
Cyclo Therapeutics Receives Grant Notice F...
07/29/2024 13:05:50

cyclo-therapeutics-has-been-granted-european-patent-number-ep3873604-titled-methods-for-treating-alzheimers-disease-with-hp-beta-cyclodextrin
Cyclo Therapeutics Has Been Granted Europe...
07/22/2024 17:02:35

https://register.epo.org/application?number=EP19805439

hc-wainwright--co-reiterates-buy-on-cyclo-therapeutics-maintains-3-price-target
HC Wainwright & Co. Reiterates Buy on Cycl...
05/31/2024 10:17:42

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Cyclo Therapeutics (NASDAQ:CYTH) with a Buy and maintains ...

cyclo-therapeutics-completes-last-patient-in-phase-3-transportnpc-trial-of-niemann-pick-type-c1
Cyclo Therapeutics Completes Last Patient ...
05/30/2024 13:04:47

TransportNPC™ is the most comprehensive ongoing controlled pivotal study regarding patient size, global footprint, duration and...

cyclo-therapeutics-q1-2024-gaap-eps-015-beats-019-estimate-sales-202450k-miss-376667k-estimate
Cyclo Therapeutics Q1 2024 GAAP EPS $(0.15...
05/16/2024 12:29:24

Cyclo Therapeutics (NASDAQ:CYTH) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(...

hc-wainwright--co-initiates-coverage-on-cyclo-therapeutics-with-buy-rating-announces-price-target-of-3
HC Wainwright & Co. Initiates Coverage On ...
05/01/2024 10:13:28

HC Wainwright & Co. analyst Swayampakula Ramakanth initiates coverage on Cyclo Therapeutics (NASDAQ:CYTH) with a Buy rat...

ascendiant-capital-initiates-coverage-on-cyclo-therapeutics-with-buy-rating-announces-price-target-of-26
Ascendiant Capital Initiates Coverage On C...
04/22/2024 09:40:07

Ascendiant Capital analyst Lucas Ward initiates coverage on Cyclo Therapeutics (NASDAQ:CYTH) with a Buy rating and announces...

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
04/18/2024 20:31:32

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION